AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Director's Dealing 2021

Nov 19, 2021

33153_dirs_2021-11-19_6426f618-e3bc-4144-afb7-62b089551e37.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MESA LABORATORIES INC /CO/ (MLAB)
CIK: 0000724004
Period of Report: 2021-11-15

Reporting Person: Ladiwala Shiraz Shabanali (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-15	Restricted Stock Units - 1	$	A	405	Acquired		Common Stock (405)	Direct

Footnotes

F1: Each RSU represents a contingent right to receive one share of the Issuers commo stock

F2: Represents 282 RSUs related to a pro-rated annual grant and 123 RSUs granted for the conversion of cash compensation for Board of Directors services for the next 9 months

F3: RSUs that vest August 15, 2022

F4: Not applicable